Edgar Filing: Monarch Alternative Capital LP

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Monarch Alternative Capital LP

2. Issuer Name and Ticker or Trading Symbol
Cimarex Resolute LLC [REN]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	__X__ Other (specify below)
See Remarks

(Last)

(First)

(Middle)

535 MADISON AVENUE, 26TH FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2019

(Street)

NEW YORK, NY 10022

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.0001 per share ("Common Stock")	03/01/2019		D		1	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽³⁾
Common Stock	03/01/2019		D		2,770	D	⁽¹⁾	0	D ⁽⁴⁾
Common Stock	03/01/2019		D		70,868	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽⁵⁾
Common Stock	03/01/2019		D		543,931	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽⁶⁾
Common Stock	03/01/2019		D		452,297	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽⁷⁾
Common Stock	03/01/2019		D		862,721	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽⁸⁾
Common Stock	03/01/2019		D		338,254	D	⁽¹⁾	0	I	See footnotes ⁽²⁾ ⁽⁹⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Monarch Alternative Capital LP 535 MADISON AVENUE 26TH FLOOR NEW YORK, NY 10022	X			See Remarks
MDRA GP LP C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE, 26TH FLOOR NEW YORK, NY 10022	X			See Remarks
Monarch GP LLC C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE, 26TH FLOOR NEW YORK, NY 10022	X			See Remarks

Signatures

/s/ Michael Weinstock, Member		03/04/2019
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	See Exhibit 99.1
(2)	See Exhibit 99.1
(3)	See Exhibit 99.1
(4)	See Exhibit 99.1
(5)	See Exhibit 99.1
(6)	See Exhibit 99.1
(7)	See Exhibit 99.1
(8)	See Exhibit 99.1
(9)	See Exhibit 99.1
Remarks: Joseph Citarrella, a Managing Principal of Monarch Alternative Capital LP, served on the board of directors of the Issuer as a representative of Monarch Alternative Capital LP. As a result, each of Monarch Alternative Capital LP, and by virtue of their control of Monarch Alternative Capital LP, MDRA GP LP and Monarch GP LLC is a "director-by-deputization" solely for purposes of Section 16 of the Exchange Act. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Information and Signatures

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.